IP Library Granted Patent US 10,967,021
Granted Patent B2
US 10,967,021 · App. 16/159,364 · Granted Apr 6, 2021

Oral compositions and route of administration for the delivery of a thylakoid extract

Inventors: Marc Purcell (Saint-Augustin-de-Desmaures, CA); Réjean Drouin (St-Gilles de Lotbinière, CA)
Assignee: GROUPE SANTÉ DEVONIAN
A61K36/21A23L33/105A61K9/0053A61K36/00A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,967,021
App. No.
16/159,364
Granted
Apr 6, 2021
Kind
B2
Abstract

The present invention provides a new use or method of use of a thylakoid extract, for oral route of administration, and a composition comprising the thylakoid extract in adjunction with an acceptable carrier for oral administration. Besides the pharmaceutical use, the thylakoid extract enters the composition of food or food supplements, or medication for its innocuity and its capacity to provide a diet enriched in anti-oxidants and anti-inflammatory compounds. Therefore, in accordance with the present invention is provided the use of athylakoid extract in the making of an oral composition for treating preventing a disease or disorder involving the formation of reactive oxygen species or inflammation. Also is provided a method for treating or preventing a disease or disorder involving the formation of reactive oxygen species inflammation in an individual, which comprises the step of orality administering an effective dose of a thylakoid extact. Further is provided an oral composition comprising a thylakoid extract and a vehicle for oral ingestion or oral administration. An oral composition comprising purified thylakoids and a carrier for oral ingestion or oral administration, with the proviso that the carrier does not essentially consists of water, physiological saline or propylene glycol is also provided as food or a food supplement, or as a peliet, or encapsulated granules or powder. The carrier may be present in an amount of 0.01% to 95% (w/w) of the total composition. The purified thylakoids are present in an amount which achieves a dosage of 0.1 to 10 mg per Kg of a subject's body weight.

Claims (11)

1. A method for manufacture of an oral composition, the method comprising the steps of:

mixing a purified active thylakoid extract with an orally-acceptable non-aqueous carrier, wherein the composition when ingested in a subject, has antioxidant and anti-inflammatory activity.

2. The method of claim 1 , wherein the purified active thylakoid extract is present in an amount between 1 to 1000 mg.

3. The method of claim 1 , wherein the carrier is present in an amount of 0.01% to 95% (w/w) of the total composition.

4. The method of claim 1 , wherein the oral composition is a food supplement.

5. The method of claim 1 , wherein the oral composition is a medication.

6. The method of claim 1 , further comprising the step of: pressing said mixture to form a pellet.

7. The method of claim 6 , wherein said pellet comprises from 200 to 300 mg of purified active thylakoid extract.

8. The method of claim 1 , further comprising the step of: encapsulating said mixture in a capsule.

9. The method of claim 8 , wherein said capsule comprises from 200 to 300 mg of purified active thylakoid extract.

10. The method of claim 1 , further comprising the step of: mixing the oral composition with a food component to form a food composition, wherein said oral composition prevents oxidative damages to the food component of the food composition.

Assignments (5)
SECURITY INTEREST Recorded Feb 23, 2024
From: DEVONIAN HEALTH GROUP INC.
To: FIERA PRIVATE DEBT INC.
Reel/Frame 066539/0690 →
RELEASE OF SECURITY INTEREST Recorded Jan 30, 2024
From: GRX HEALTHCARE INC.
To: GROUPE SANTÉ DEVONIAN INC.
Reel/Frame 066287/0652 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NO. 16154364 PREVIOUSLY RECORDED AT REEL: 048359 FRAME: 0174. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Jun 28, 2021
From: DEVONIAN HEALTH GROUP INC.
To: GRX HEALTHCARE INC.
Reel/Frame 057292/0433 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2021
From: PURGENESIS TECHNOLOGIES INC.
To: GROUPE SANTE DEVONIAN
Reel/Frame 055345/0411 →
SECURITY INTEREST Recorded Feb 18, 2019
From: DEVONIAN HEALTH GROUP INC.
To: GRX HEALTHCARE INC.
Reel/Frame 048359/0174 →